Unlike traditional skin creams that only target the dead cells on the surface of the skin (the epidermis), our technology targets the functional cells in the deeper layer of the skin called the dermis.
Teloskin’s technology targets functional cells in the dermis to prevent live skin cells from reaching their divisional limits. This allows them to divide many more times, maintaining their protein production for collagen, elastin, and hyaluronic acid.
Our mission is to revolutionize skincare by pioneering patented products that extend telomeres, inhibit the activity of interleukin 17 (IL-17), prevent senescent cells, boost mitochondria, and regulate epigenetic expression. We offer a unique, biology-based approach to combating skin aging by merging cutting-edge science with nature’s finest ingredients.
We believe skin aging can be managed, slowed, and in some aspects reversed when skin cell populations are increased. This leads to higher levels of essential proteins such as collagen, elastin, fibronectin, laminin, and hyaluronic acid.
Raymond D. Palmer is our Chief Science Officer. He is trained in tissue reprogramming and has studied genetics, biochemistry, epigenetics, cell biology, gene editing, immunology and inflammation, drug delivery systems, and nucleic acid therapeutics through Harvard University.
Ray collaborates with numerous universities in Australia and America, as well as biotech companies, to develop technologies that can rewind time in skin and other major human tissues. His focus is human aging, and Teloskin was created to address the true drivers of skin aging at the cellular level.
Teloskin Pty Ltd • Perth, Western Australia
© 2026 All Rights Reserved